ICUI logo

ICU MEDICAL INC

ICUINASDAQ
πŸ† #1130 by market capEarnings Nov 5US Equity
$182.08β–Ό $0.35 (βˆ’0.19%)
πŸŒ™ After hours$183.03β–² 0.52%Regular close Β· extended-hours price shown
1hβ€”
24hβ–Ό 0.2%
7dβ–² 9.3%
14dβ–² 9.4%
30dβ–² 15.6%
1yβ–² 65.2%
🏦Market Cap
$4.55B
Small Cap
πŸ“ˆRevenue Growth (YoY)
-10.9%
Declining
πŸ“ŠGross Margin
37.9%
Healthy
πŸ’΅FCF Margin
3.9%
Moderate
βš–οΈP/S Ratio
2.1x
Cheap
Otter Score
56
Weak

Trading Snapshot

Day Range
$179.34 – $185.13
52-Week Range
$107.00 – $192.85
Volume
$2.70B
Avg Volume
$2.99B
Shares Outstanding
25.0M
Next Earnings
Oct 2, 2026

Fundamentals Snapshot

Annual Revenue
$2.23B
Last Q Revenue
$552M
P/E Ratio
99.6
P/S Ratio
2.1x
EPS (TTM)
$1.85
Dividend Yield
β€”

Why Investors Own ICUI

  • βœ“High-growth profile β€” revenue up +51.6% YoY with expanding US Equity exposure.
  • βœ“Healthy economics β€” 29% gross margin and 22% free-cash-flow margin.
  • βœ“New products and segments could unlock additional revenue streams.
⚠️ Key Risks

Execution delays, intensifying competition, and valuation compression if growth decelerates.

Financial Trends

Revenue (TTM)
$2.23Bβ–² +47.4% YoY
Gross Margin (TTM)
28.9%β–Ό βˆ’0.1% YoY
Operating Income (TTM)
$479Mβ–² +47.4% YoY
Free Cash Flow (TTM)
$479Mβ–² +47.4% YoY

About ICU MEDICAL INC

ICU Medical, Inc., operating globally through its subsidiaries, is a medical technology firm that specializes in the development, manufacture, and sale of devices for both infusion therapy and critical care. Their extensive product line for infusion therapy encompasses: Needlefree Connectors: Such as the MicroClave, MicroClave Clear, and NanoClave brands. Catheter Maintenance & Disinfection: Including Neutron patency devices and SwabCap/SwabTip disinfecting caps. Hemodialysis Solutions: Like Tego connectors and ClearGuard HD antimicrobial caps. Hazardous Drug Handling: With closed system transfer devices (ChemoClave, ChemoLock) and the Diana compounding system for safe preparation. They also provide a comprehensive range of intravenous (IV) solutions, diluents, and irrigation fluids, available in diverse packaging options like flexible containers and pour bottles. These include common formulations such as sodium chloride, dextrose, balanced electrolytes, lactated ringer's, mannitol, and sterile water, alongside specialized irrigation solutions like acetic acid and glycine. In medication management, ICU Medical offers sophisticated infusion pumps, including the Plum 360 and LifeCare PCA brands. Its advanced ICU Medical MedNet software enhances medication safety by integrating smart pumps with hospital electronic health records (EHRs), asset tracking, and alarm notification platforms. Accompanying professional services are also provided. For critical care environments, their portfolio features: Hemodynamic Monitoring: Systems like Cogent 2-in-1 and CardioFlo. Cardiac Output & Oximetry: TDQ, OptiQ, and TriOx catheters. Blood Pressure Transducers: Such as Transpac. Blood Sampling Systems: Including the SafeSet closed blood sampling and conservation systems. The company distributes its products to a wide spectrum of healthcare providers, including acute care hospitals, wholesalers, ambulatory clinics, and various alternate site facilities such as outpatient clinics, home healthcare services, and long-term care centers. Established in 1984, ICU Medical maintains its headquarters in San Clemente, California.

🦦

Otter Score Breakdown

β“˜
πŸ’ŽQualityβ˜…β˜…β˜…β˜…β˜…
πŸš€Growthβ˜…β˜…β˜…β˜…β˜…
βš–οΈValuationβ˜…β˜…β˜…β˜…β˜…
⚑Momentumβ˜…β˜…β˜…β˜…β˜…
Overall Score
Weak
56/100

Analyst Price Target

β“˜
Average Target
$231.02
β–² +26.9% Upside
High Target$280.28
Low Target$175.30
Based on 26 analysts

Latest News & Updates